{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:13:49Z","timestamp":1790802829346,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007917","name":"Agricultural Research Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T01:08:57Z","timestamp":1592960937000},"page":"5507-5515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-3712","authenticated-orcid":false,"given":"Helena L.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Reilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan R.A.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4582-6116","authenticated-orcid":false,"given":"David L.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.06.004_b0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-019-00599-8","article-title":"Classify viruses - the gain is worth the pain","volume":"566","author":"Kuhn","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.06.004_b0010","unstructured":"Lamb RA, Parks G. Paramyxoviridae. In: Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 957\u201395."},{"key":"10.1016\/j.vaccine.2020.06.004_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3354\/dao02023","article-title":"Phylogenetic relationships in the family alloherpesviridae","volume":"84","author":"Waltzek","year":"2009","journal-title":"Diseases Aquatic Organisms"},{"key":"10.1016\/j.vaccine.2020.06.004_b0020","unstructured":"OIE. CHAPTER 10.9. Newcastle Disease. In: OIE, editor. Terrestrial Animal Health Code 2014. 25th ed.; 2014."},{"key":"10.1016\/j.vaccine.2020.06.004_b0025","unstructured":"Miller PJ, Koch G. Newcastle disease. In: Swayne D, editor. Diseases of poultry. 13th ed. Ames, IA.: John Wiley & Sons, Inc.; 2013. p. 89\u2013107; 20\u201330."},{"key":"10.1016\/j.vaccine.2020.06.004_b0030","unstructured":"OIE. Detailed country (ies) disease incidence; 2018. http:\/\/www.oie.int\/wahis_2\/public\/wahid.php\/Diseaseinformation\/statusdetail."},{"key":"10.1016\/j.vaccine.2020.06.004_b0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.dci.2013.04.012","article-title":"Immune responses of poultry to Newcastle disease virus","volume":"41","author":"Kapczynski","year":"2013","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2020.06.004_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","article-title":"Newcastle disease vaccines-a solved problem or a continuous challenge?","volume":"206","author":"Dimitrov","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.06.004_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1079\/WPS20030011","article-title":"Review of Newcastle disease virus with particular references to immunity and vaccination","volume":"59","author":"Al-Garib","year":"2003","journal-title":"World's Poult Sci J"},{"key":"10.1016\/j.vaccine.2020.06.004_b0050","first-page":"165","article-title":"Control of Newcastle disease by vaccination","volume":"119","author":"Senne","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2020.06.004_b0055","unstructured":"Grimes SE. Newcastle disease vaccines: an overview. In: Grimes SE, editor. A Basic Laboratory Manual for the Small-Scale Production and Testing of I-2 Newcastle Disease Vaccine. Bangkok: FAO- RAP publication 2002\/22; 2002."},{"key":"10.1016\/j.vaccine.2020.06.004_b0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1637\/10043-122011-Reg.1","article-title":"Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype","volume":"56","author":"Cornax","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3382\/ps\/pex339","article-title":"Evaluation of the effect of live LaSota Newcastle disease virus vaccine as primary immunization on immune development in broilers","volume":"97","author":"Martinez","year":"2018","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2020.06.004_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2307\/1591341","article-title":"Effect of breeder vaccination on immunization of progeny against Newcastle disease","volume":"34","author":"Giambrone","year":"1990","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1751-0813.1984.tb07121.x","article-title":"Comparison of the immunogenicity of Newcastle disease virus strains V4, Hitchner B1 and La Sota in chickens. 2. Tests in chickens with maternal antibody to the virus","volume":"61","author":"Westbury","year":"1984","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2020.06.004_b0080","unstructured":"Armour NK, Garc\u00eda M. Current and Future Applications of Viral-Vectored Recombinant Vaccines in Poultry The Poultry informed professional. 2014; July-August: 1\u20139."},{"key":"10.1016\/j.vaccine.2020.06.004_b0085","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2307\/1592296","article-title":"Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens","volume":"40","author":"Heckert","year":"1996","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2307\/1591910","article-title":"Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies","volume":"37","author":"Morgan","year":"1993","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0095","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1637\/10540-032613-Reg.1","article-title":"Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine","volume":"57","author":"Esaki","year":"2013","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vetimm.2013.11.008","article-title":"Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers","volume":"158","author":"Palya","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.06.004_b0105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.vaccine.2009.10.049","article-title":"Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old","volume":"28","author":"Rauw","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.004_b0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1637\/9935-091511-Reg.1","article-title":"Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions","volume":"56","author":"Palya","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2008.10.094","article-title":"Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers","volume":"27","author":"Le Gros","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.004_b0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1040638718784920","article-title":"Diagnosis of virulent Newcastle disease in southern California, May 2018","volume":"30","author":"Carvallo","year":"2018","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2020.06.004_b0125","first-page":"411","article-title":"Emergency declared: exotic Newcastle disease found in commercial poultry farms","volume":"222","author":"Nolen","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2020.06.004_b0130","doi-asserted-by":"crossref","unstructured":"Dimitrov KM, Ferreira HL, Pantin-Jackwood M, Taylor T, Goraichuk IV, Crossley BM, et al. Pathogenicity and transmission of virulent Newcastle disease virus from the 2018\u20132019 California outbreak and related viruses in young and adult chickens. Virology. 2019;March. http:\/\/dx.doi.org\/10.1016\/j.virol.2019.03.010.","DOI":"10.1016\/j.virol.2019.03.010"},{"key":"10.1016\/j.vaccine.2020.06.004_b0135","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1016\/j.vaccine.2005.01.140","volume":"23","author":"Kapczynski","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.004_b0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1637\/8407-071208-Reg.1","article-title":"Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses","volume":"53","author":"Miller","year":"2009","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0145","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2007.07.017","article-title":"Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge","volume":"25","author":"Miller","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.004_b0150","series-title":"A laboratory manual for the isolation, identification and characterization of avian pathogens","first-page":"204","article-title":"Virus propagation in embryonating eggs","author":"Senne","year":"2008"},{"key":"10.1016\/j.vaccine.2020.06.004_b0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jviromet.2004.03.006","article-title":"Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction","volume":"119","author":"Islam","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.06.004_b0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1637\/7552-033106R.1","article-title":"A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification","volume":"51","author":"Van Borm","year":"2007","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2020.06.004_b0165","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/104063870902100603","article-title":"Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of Avian influenza virus by RT-PCR","volume":"21","author":"Das","year":"2009","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2020.06.004_b0170","unstructured":"OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. In: (2017) MotOCC, editor. 8th ed.; 2017."},{"key":"10.1016\/j.vaccine.2020.06.004_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virusres.2005.11.009","article-title":"Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications","volume":"120","author":"Czegledi","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.06.004_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103917","article-title":"Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus","volume":"74","author":"Dimitrov","year":"2019","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2020.06.004_b0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dci.2013.06.007","article-title":"Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses","volume":"41","author":"Miller","year":"2013","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2020.06.004_b0190","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/03079457.2011.588196","article-title":"Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination","volume":"40","author":"Gimeno","year":"2011","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2020.06.004_b0195","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3382\/ps.0361076","article-title":"Newcastle disease immunization studies: 4. vaccination of chickens with B1, F and lasota strains of newcastle disease virus administered through the drinking water","volume":"36","author":"Winterfield","year":"1957","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2020.06.004_b0200","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3382\/ps.0590240","article-title":"Vaccination of chickens against Newcastle disease with live and inactivated Newcastle disease virus","volume":"59","author":"Winterfield","year":"1980","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2020.06.004_b0205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/03079457.2014.966302","article-title":"Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt","volume":"43","author":"Kilany","year":"2014","journal-title":"Avian Pathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:41Z","timestamp":1759402001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307659"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}